These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37036017)

  • 1. Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis.
    Min L; Chen J; Yu M; Yang K; Liu D
    Biomarkers; 2023 Dec; 28(5):427-436. PubMed ID: 37036017
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis.
    Zhang H; Jin T; Peng Y; Luan S; Li X; Xiao X; Yuan Y
    Int J Surg; 2024 Jul; 110(7):4370-4381. PubMed ID: 38526514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
    Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
    Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
    JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
    Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J
    Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
    Gao Y; Xi H; Wei B; Cui J; Zhang K; Li H; Cai A; Shen W; Li J; Rosell R; Chao J; Chen T; Klempner S; Qiao Z; Chen L
    Front Oncol; 2019; 9():1222. PubMed ID: 31850190
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis.
    Liu H; Chen J; Huang Y; Zhang Y; Ni Y; Xu N; Zhao F; Tang Y; Liu H; Sun G; Shen P; Liu Z; Huang J; Liao B; Zeng H
    Int J Surg; 2024 Jun; 110(6):3923-3936. PubMed ID: 38573063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer.
    Zhou H; Liu H; Li J; Wang J; Fu X; Li Y; Mao S; Du J
    Genes Genomics; 2023 Aug; 45(8):1037-1046. PubMed ID: 37306927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis.
    Zheng J; Qin C; Wang Q; Tian D; Chen Z
    EBioMedicine; 2024 May; 103():105109. PubMed ID: 38614009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.
    O'Sullivan NJ; Temperley HC; Kyle ET; Sweeney KJ; O'Neill M; Gilham C; O'Sullivan J; O'Kane G; Mehigan B; O'Toole S; Larkin J; Gallagher D; McCormick P; Kelly ME
    Int J Colorectal Dis; 2024 May; 39(1):82. PubMed ID: 38809315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor DNA and Survival in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
    Dickinson K; Sharma A; Agnihotram RV; Altuntur S; Park M; Meterissian S; Burnier JV
    JAMA Netw Open; 2024 Sep; 7(9):e2431722. PubMed ID: 39235812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Circulating Tumour DNA in Asian Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Liu H; Yang H; Chen X
    Evid Based Complement Alternat Med; 2022; 2022():8019652. PubMed ID: 35251214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
    Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P
    Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis.
    Yao L; Xu H; Wo J; Zhao M; Liu Z; Dong T; Xiao S
    Clin Exp Med; 2022 Feb; 22(1):1-7. PubMed ID: 33990849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis.
    Chen D; Guo J; Huang H; Tian L; Xie Y; Wu Q
    BMC Med; 2023 Nov; 21(1):467. PubMed ID: 38012727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
    Zhang Y; Du H; Wang N; Wang L; Huang Y
    BMC Cancer; 2024 Jan; 24(1):129. PubMed ID: 38267901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer.
    Zhang M; Yang H; Fu T; Meng M; Feng Y; Qu C; Li Z; Xing X; Li W; Ye M; Li S; Bu Z; Jia S
    Mol Oncol; 2023 Sep; 17(9):1930-1942. PubMed ID: 37356061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.